How do regional factors influence psoriasis patient care in Germany?;Welchen Einfluss haben regionale Faktoren auf die Versorgung der Psoriasis in Deutschland?

JDDG - Journal of the German Society of Dermatology

Volumn 8, Issue 7, 2010, Pages 516-523

  Radtke, Marc Alexander ^a   Augustin, Jobst ^a   Blome, Christine ^a   Reich, Kristian ^b   Rustenbach, Stephan J ^a   Schäfer, Ines ^a   Laass, Anna ^a   Augustin, Matthias ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Dermatologikum Hamburg   (Germany)

Author keywords

health care; health services research; psoriasis; quality of care

Indexed keywords

ADULT; ARTICLE; BIOLOGICAL THERAPY; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DISEASE SEVERITY; FEMALE; GEOGRAPHIC DISTRIBUTION; GERMANY; HEALTH CARE QUALITY; HEALTH SERVICES RESEARCH; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PSORIASIS; PSORIASIS SEVERITY INDEX; QUALITY OF LIFE; SYSTEMIC THERAPY;

EID: 77954074576     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2010.07358.x     Document Type: Article

References (32)

1. Schaefer I, Zimmer L, Rustenbach SJ, Augustin M. Prevalence of Skin Disease in a Cohort of 48,655 Employees in Germany. Dermatology 2008 217 : 169 172.
2. Gulliver W. Long-term prognosis in patients with psoriasis. Br J Dermatol 2008 159 : 2 9.
3. Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, Wang X, Margolis DJ, Strom BL. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007 143 : 1493 1499.
4. Sterry W, Strober BE, Menter A. Obesity in psoriasis:the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007 157 : 649 655.
5. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 55 : 829 835. (Pubitemid 44556851)
6. Gottlieb AB, Chao C, Dann F. Psoriasis comorbidities. J Dermatolog Treat 2008 19 : 5 21.
7. Ortonne JP. Psoriasis, metabolic syndrome and its components. Ann Dermatol Venereol 2008 135 : 235 242.
8. Nast A, Kopp IB, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B Deutsche Dermatologische Gesellschaft (DDG); Berufsverband Deutscher Dermatologen (BVDD). Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris. J Dtsch Dermatol Ges 2007 5 : 1 119.
9. Nast A, Reytan N, Rosumeck S, Erdmann R, Rzany B. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry. J Eur Acad Dermatol Venereol 2008 23 : 1337 1342.
10. Reich K, Mrowietz U. Treatment goals in psoriasis. J Dtsch Dermatol Ges 2007 5 : 566 574.
11. Weisenseel P, Kuznetsov AV, Prinz JC. Implementation of the S3-guidelines for systemic and UV therapy of moderate to severe psoriasis vulgaris by an algorithm. J Dtsch Dermatol Ges 2007 5 : 683 688.
12. Augustin M, Luger T, Reusch M. Versorgungsqualität der Psoriasis in Deutschland. Gesellschaftspolitische Kommentare. 2008 1 : 10 8.
13. Sohn S, Schöffski O, Prinz K, Schubert E, Waldorf K, Augustin M. Cost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness study. Dermatology 2006 212 : 137 144.
14. Berger K, Ehlken B, Kugland B, Augustin M. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany. J Dtsch Dermatol Ges 2005 3 : 511 518.
15. Augustin M, Reich K, Reich C, Purwins S, Rustenbach SJ, Schäfer I, Radtke MA. Quality of psoriasis care in Germany - results of the national study PsoHealth 2007. J Dtsch Dermatol Ges 2008 6 : 640 645.
16. Augustin M, Krüger K, Radtke MA, Schwippl I, Reich K. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 2008 216 : 366 372.
17. Schöffski O, Augustin M, Prinz J, Rauner K, Schubert E, Sohn S, Reich K. Krankheitskosten und Lebensqualität bei Patienten mit mittelschwerer bis schwerer Psoriasis vulgaris in Deutschland: Eine multizentrische Studie. J Dtsch Dermatol Ges 2007 5 : 209 219.
18. Augustin M. PsoNet - more health care quality through regional psoriasis networks. J Dtsch Dermatol Ges 2008 6 : 263 264.
19. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008 159 : 997 1035.
20. Radtke M, Reich K, Reich C, Kopp I, Rustenbach SJ, Schäfer I, Augustin M. Evaluation of quality of care and guideline-compliant treatment in psoriasis: development of a new system of quality indicators. Dermatology 2009 219 (1 54 8.
21. Augustin M, Reich C, Schaefer I, Zschocke I, Rustenbach SJ. Development and validation of a new instrument for the assessment of patient-defined benefit in the treatment of acne. J Dtsch Dermatol Ges 2008 6 : 113 120.
22. Schäfer I, Radtke M, Glaeske G, Augustin M. Epidemiologie der Psoriasis in Deutschland: Auswertung von Routinedaten einer gesetzlichen Kranken-versicherung. J Dtsch Dermatol Ges 2009 4 : 194.
23. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 2005 125 : 659 664.
24. Finlay AY, Khan GK. Dermatology Life quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994 19 : 210 216.
25. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995 132 : 236 244.
26. Augustin M, Zschocke I, Seidenglanz K, Lange S, Schiffler A, Amon U. Validation and clinical results of the FLQA-d, a quality of life questionnaire for patients with chronic skin diseases. Dermatol Psychosom 2000 1 : 12 7.
27. Augustin M, Zschocke I, Lange S, Seidenglanz K, Amon U. Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis. Hautarzt 1999 50 : 715 722.
28. Touw CR, Hakaart-van-Roijen L, Verboom P, Rutten FFH, Finlay A. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporine. Br J Dermatol 2001 144 : 967 972.
29. Revicki DA, Willian MK, Menter A, Saurat JH, Harnam N, Kaul M. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis. Dermatology 2008 216 : 260 270.
30. Reich K, Griffiths CE. The relationship between quality of life and skin clearance in moderate-to severe psoriasis: lessons learnt from clinical trials with infliximab. Arch Dermatol Res 2008 300 : 537 544.
31. O'Malley AS, Clancy C, Thompson J, Korabathina R, Meyer GS. Clinical practice guidelines and performance indicators as related - but often misunderstood tools. Jt Comm J Qual Saf 2004 30 : 163 171.
32. Augustin M. PsoNet - mehr Versorgungsqualität durch regionale Psoriasisnetze (Editorial). J Dtsch Dermatol Ges 2008 6 : 263 264.